Sarah B. Noonberg - 06 Jun 2025 Form 4 Insider Report for Metagenomi, Inc. (MGX)

Reporting relationship: Chief Medical Officer
Issuer ticker: MGX
Reported as of: 06 Jun 2025
Net transaction value: -$9,168
SEC form: 4
Accepted by SEC: 09 Jun 2025, 18:57:07 UTC
Prior SEC filing: 03 Apr 2025
Next SEC filing: 13 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Matthew L. Wein, attorney-in-fact

Key filing fact

Sarah B. Noonberg filed Form 4 for Metagenomi, Inc. (MGX) on 09 Jun 2025.

Key facts

This page summarizes Sarah B. Noonberg's Form 4 filing for Metagenomi, Inc. (MGX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Jun 2025, 18:57.

Change

Previous filing in this sequence was filed on 03 Apr 2025.
Current net transaction value: -$9,168.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001706301 Primary reporting owner

Noonberg Sarah B.

Relationship: Chief Medical Officer
Address: C/O METAGENOMI, INC., 5959 HORTON STREET, 7TH FLOOR, EMERYVILLE
Signature: /s/ Matthew L. Wein, attorney-in-fact
Signature date: 09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MGX transaction

Common Stock

Sale

Transaction value: $9,168
Shares: -5,239
Change %: -4.6%
Price: $1.75
Shares after: 109,135
Date: 06 Jun 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.